AAX Biotech Wins Nordic Star Pitch Competition
AAX Biotech has been selected as the winner of the Nordic Star 2026 Pitch Competition held in Stockholm. The company was recognized for its technologies, Opti-mAb® and Seqitope®.
AAX Biotech was named the winner of the Nordic Star 2026 Pitch Competition, held in Stockholm on September 8–9, 2026. The event featured 13 other Nordic small and medium-sized enterprises at the forefront of life science.
Company CEO/CSO Daniel X. Johansson presented AAX Biotech's technologies, Opti-mAb® and Seqitope®, to a jury of experienced investors. The jury awarded the prize, citing "a highly sophisticated, high impact solution with a clear business case."
The Nordic Star competition is part of NLSDays, an event focused on the life science sector. The award acknowledges the potential and commercial viability of AAX Biotech's advanced technologies, which aim to develop new medical devices and therapeutic treatments.